Insulet Corporation
9 Oak Park Drive
Bedford,
MA 01730
United States - Map
Phone: 781-457-5000
Fax: 781-457-5011
Web Site: http://www.insulet.com
| Insulet Corporation, a medical device company, engages in the development, manufacture, and marketing of an insulin infusion system for people with insulin-dependent diabetes in the United States. The company offers OmniPod Insulin Management System (OmniPod System), an insulin infusion system that provides a pain-free automated cannula insertion. It consists of OmniPod disposable insulin infusion device and handheld wireless personal diabetes manager; and provides people with a diabetes management solution that offers lifestyle and other benefits. Insulet Corporation has an agreement with Ferring Pharmaceuticals to develop the OmniPod System for the delivery of a Ferring drug. It serves healthcare professionals, people with insulin-dependent diabetes, and third-party payors. The company sells the OmniPod System directly to patients through referrals from healthcare professionals and through patient leads. Insulet Corporation was founded in 2000 and is headquartered in Bedford, Massachusetts. |
|
| Key Statistics |
| |
| | Pay | Exercised | Mr. Duane DeSisto , 54
Chief Exec. Officer, Pres |
$
429.00K |
$
0 | Mr. Luis J. Malavé , 46
Chief Operating Officer |
$
316.00K |
$
3.48M | Mr. Carsten Boess , 42
VP of International Operations |
$
336.00K |
$
0 | Mr. Lars Boesgaard , 39
VP of Fin. and Sr. Fin. Advisor |
$
247.00K |
$
0 | Mr. John T. Garibotto , 44
Co-Founder |
N/A
| N/A |
|
|
|
Dollar amounts are as of
31-Dec-08
and compensation values are for the last fiscal
year ending on that date. "Pay" is salary, bonuses, etc. "Exercised" is the value of
options exercised during the fiscal year.
| |
|
1.48% Nasdaq 
0.02 (0.16%) 
Profile
